Considerable controversy has revolved about the nature of the disturbed iron metabolism in patients with rheumatoid arthritis and the question whether the depositions of iron in the synovial tissues of these patients represent beneficial or harmful events (Mowat and Hothersall, 1968) . Lawson, Owen, and Mowat (1967) showed that there was an increase in the urinary excretion of iron in patients with rheumatoid arthritis compared with controls after the administration of the chelating agent desferrioxamine B. It was considered that these results provided evidence of increased iron storage in these patients. Subsequently Mowat and Hothersall (1968) and Senator and Muirden (1968) showed considerably higher concentrations of iron in the synovial tissue of patients with rheumatoid arthritis compared with controls. Since there is proliferation of the synovial tissue in these patients, relatively large quantities of iron could be deposited in this tissue. The iron is present in the synovial tissue in the form of ferritin and has a distinctive appearance under light or electron microscopy (Muirden, 1966) . A similar increase in the quantity of ferritin and in its distribution to that found in patients with rheumatoid arthritis has been noted in experimental arthritis induced in rabbits with caragheenin, Freund's adjuvant, and tuberculin (Muirden and Peace, 1969) . Muirden (1966 Muirden ( , 1970 and Muirden, Fraser, and Clarris (1967) suggested that the ferritin was deposited in the synovial tissue as the end-result of repeated small haemorrhages and subsequent erythrophagocytosis by the synovial lining cells.
This mechanism could possibly explain the findings in rheumatoid arthritis as red blood cells in small numbers can be found in many joint effusions in these patients. However, it is less easily invoked as the mechanism involved in the experimental arthritides which are of short duration.
A reduced clearance of Fe59-labelled erthrocytes from the knee joints of rabbits with caragheenin arthritis compared with controls (Muirden, 1969) with subsequent deposition of iron in the synovial tissue has been described (Muirden, Peace, and Rogers, 1969) . This confirms the work of Roy and Ghadially (1966) , who demonstrated the ability of rabbit synovial tissue to form ferritin from erythrocytes, and of Muirden and others (1967) , who showed the formation of ferritin by human synovial cells in culture on exposure to haemoglobin. However, it is possible that the iron might reach the synovial tissue by transfer from the plasma or synovial fluid. The presence of a low serum iron level and an equally low synovial fluid iron (Senator and Muirden, 1966;  personal observations) does not exclude the possibility of an iron gradient. Rabbit synovial tissue has also been shown to form ferritin from iron-dextran (Ball, Chapman, and Muirden, 1964) . Thus it is clear that synovial tissue has the capacity to form ferritin from haemoglobin or elemental iron, but the source of the iron has not been determined. Muirden (1966) and Muirden and others (1969) have suggested that the presence of iron in the synovial tissue might be harmful and might lead to the release of lysosomal enzymes, resulting in damage to the joint. There is no evidence for this mechanism. In addition, iron stored in the synovial tissue in haemochromatosis is not the cause of the associated arthropathy, which is essentially degenerative in nature (Hamilton, Williams, Barlow, and Smith, 1968; Wardle and Patton, 1969) . Richmond, Roy, Gardner, Alexander, and Duthie (1958) showed that a 5 g. course of saccharated oxide of iron, given intravenously to patients with rheumatoid arthritis, was followed not only by an increase in the haemoglobin concentration but also by a reduction in the erythrocyte sedimentation rate and in the activity of the disease and by an improvement in the functional capacity of the patient. It seems possible, therefore, that the iron in the synovial tissue could be derived from the plasma and might exercise a beneficial rather than harmful effect.
The present investigation was designed to test in an experimental synovitis in guinea-pigs whether in fact iron was harmful or beneficial and to compare the effect of iron with known anti-inflammatory agents.
Material and methods An acute synovitis, which persisted if untreated for over 7 days, was induced in one elbow joint of 3 to 400 g. guinea-pigs by the intra-articular injection of the polyene antibiotic Nystatin (10,000 i.u. in 01-ml. physiological saline) (Weissmann, Pras, and Rosenberg, 1967) . The synovitis did not appear to be accompanied by any systemic reaction. This synovitis was used as a model in which to test the effect of intra-articular injections of various drugs with proved or possible anti-inflammatory activity. Since it was found in initial experiments that slightly better control of the synovitis was achieved by injecting the test substances 24 hrs before the Nystatin compared to 24 hrs after the Nystatin, this timetable was used throughout the study.
One elbow joint of the guinea-pigs was injected with iron-dextran (Imferon) in a concentration containing 100 or 200 ,ug. elemental iron; or gold thiosulphate in a concentration containing 200 or 400 ,ug. elemental gold; or 250,ug. hydrocortisone acetate. All the test materials were made up in 01-ml. physiological saline. Five to ten animals were used to assess the effect of each test material. Four animals were injected intra-articularly with Dextran (M.W. 8000) in the same concentration as in iron-dextran (200 ltg.) made up in 0-1 ml. physiological saline. 24 hrs later synovitis was induced in the same elbow joint by Nystatin and the subsequent progress of the inflammation was followed. Control animals were injected with Nystatin alone. In addition control studies were undertaken to ensure the similarity of the two (1957) . The usual precautions to avoid iron contamination of the glass-ware were observed.
The synovitis was assessed by the use of an external counting method after the intravenous injection of radioactive 1131 human serum albumin (RISA) (Mowat, Disney, and Vaughan, 1970) . The result, which is chiefly a measure of joint vascularity, was expressed as the ratio Counts per minute from the injected joint Counts per minute from the non-injected joint x 100
On this basis a value of 100 signifies no detectable inflammation. A clinical assessment of the synovitis was also carried out, but since in the earlier study (Mowat and others, 1970) this had not been shown to be as accurate as the external counting method the results are not included. The synovitis was measured at daily intervals after the injection of Nystatin for up to 7 days in those animals receiving Nystatin alone, but 4 days proved to be sufficient in those animals receiving the test injections. For the control studies external counting was carried out at 6 and 24 hrs after the test injections.
Results
Intra-articular injections of iron-dextran (200 zg. elemental iron), gold thiosulphate (400 jig. elemental gold), and 250 ,ug. hydrocortisone acetate in 0 1 ml. physiological saline, and of 0-1 ml. physiological saline alone did not produce synovitis. The results for the degree of synovitis produced by intraarticular injections of Nystatin alone, and by Nystatin 24 hrs after intra-articular injections of iron-dextran (100 and 200 pg. elemental iron), gold thiosulphate (200 and 400 /Lg. elemental gold), hydrocortisone acetate (250 pg.), and by Nystatin 24 hrs after intramuscular injections of iron-dextran (5 mg. elemental iron) are set out in Table I Dextran alone, in the same concentration as used in iron-dextran (200 ,ug.), had no effect on the synovitis. Table II shows the degree of synovitis in eighteen animals 1 and 2 days after the intra-articular injection of Nystatin. These animals had previously been injected with varying doses of iron-dextran intramuscularly and the values for the degree of synovitis are compared with the plasma iron value estimated on blood drawn on Day 1. No correlation between the degree of control of the synovitis and the plasma iron value could be demonstrated (Correlation coefficient Day 1 0 3559; Day 2 0 3003).
In only five animals was the plasma iron value greater than the mean normal plasma iron value determined on blood drawn from five animals untreated with either Nystatin or iron-dextran of 562 ,ug. per cent.
Discussion
These results support the suggestion of Richmond and others (1958) that iron has a beneficial effect on synovial inflammation. There was significant control The failure to demonstrate a direct relationship between the degree of control of the synovitis and the plasma iron value was disappointing. This probably reflects differences in the rates of uptake by the synovial tissue, of transfer from the plasma to the synovial fluid, of removal from the injection site, and of urinary excretion of the iron. In all but five cases the plasma iron value was lowered from the normal value as occurs in active rheumatoid arthritis (Nilsson, 1948) . This suggests that there is an active removal of iron from the plasma in these animals and that some control of the synovitis occurs if increased iron is made available to them.
Nystatin and the other polyene antibiotics are considered to cause inflammation by the release of lysosomal enzymes and the effect is not specific for synovial tissue (Weissmann and others, 1967) . Weissmann, Spilberg, and Krakauer (1969) have also shown that 4ysates of polymorphonuclear leucocytes produce a similar synovitis to that induced by Nystatin in studies of experimental synovitis in rabbits, and it has been postulated that the release of these lysosomal enzymes is the final pathway in any form of synovitis (Weissmann, 1966) . The mechanism by which iron achieves its effect has not been determined. Hydrocortisone has generally been believed to be a stabilizer of lysosomal membranes (de Duve, Wattiaux, and Wibo, 1962; Weissmann, 1965) , although Hempel, Fernandez, and Persellin (1970) failed to demonstrate a protective effect when isolated rabbit leucocyte lysosomes were stressed by detergent in the presence of hydrocortisone. Weissmann and others (1967) were also able to reduce the effect of intra-articular injections of the polyene antibiotics in rabbit knee-joints by prior intraarticular injection of cortisone acetate. Intraarticular injections of gold salts have been shown to have a beneficial local effect on the synovitis of rheumatoid arthritis (Lewis and Ziff, 1966) . Gold salts have been shown to inhibit lysosomal enzymes after their release (Persellin and Ziff, 1966; Ennis, Granda, and Posner, 1968; Paltenaa, 1968) . Further studies will be required to see if iron may act in a related manner either by pieventing the release of lysosomal enzymes or by inhibiting the enzymes after their release. Masson, Heremans, and Schonne (1969) have shown that polymorphonuclear leucocytes contain lactoferrin. This is an iron-binding protein similar to but chemically and antigenically different from transferrin. Lactoferrin has a stronger avidity for iron than transferrin, and this difference is enhanced in an acid pH (Masson and others, 1969) which is present in inflammatory joint lesions (Goldie and Nachemson, 1969) . This ability of the polymorphonuclear leucocyte to bind iron may explain the findings in this study and some of the abnormalities in iron metabolism in rheumatoid arthritis.
The presence of iron in the polymorphonuclear leucocyte could allow an effect on lysosomal granules to occur, and lactoferrin has been identified in the specific or secondary granules of rabbit neutrophil leucocytes (Baggiolini, de Duve, Masson, and Heremans, 1970) . The deposition of iron in the synovial lining cells, particularly those with macrophage properties, in rheumatoid arthritis (Muirden, 1966) could result from the ingestion of iron-loaded degenerate polymorphonuclear leucocytes. The combination of tissue deposition and the increased concentration of iron in the polymorphonuclear leucocytes at the expense of transferrin could explain the low plasma iron and the normal plasma ironbinding capacity in rheumatoid arthritis.
The reticuloendothelial system, of which the phagocytic lining cells of the synovial membrane can be considered a part, may take up iron directly from the synovial fluid or plasma, without the need to postulate the polymorphonuclear leucocyte as an intermediate step. Many tissues have the capacity to form apoferritin in the presence of iron and hence to produce ferritin (Gabrio and Salomon, 1950) .
It is a matter of speculation whether, on the basis of the effects of iron administered by intra-articular or intramuscular injection on an acute, self-limiting synovitis in guinea-pigs, this method of therapy should be tried or even be expected to be effective in rheumatoid arthritis. Richmond and others (1958) showed that a 5 g. course of saccharated oxide of iron given intravenously had a beneficial effect on the synovitis in patients with rheumatoid arthritis, and a 3 g. course of intravenous iron is commonly employed by some physicians (Duthie, 1967) . These doses are far in excess of those calculated to correct the anaemia in these patients. Lewis and Ziff (1966) have shown that gold salts, which are established anti-inflammatory agents in rheumatoid arthritis, have a local effect when administered intra-articularly. Ball and others (1964) found that iron-dextran caused a transient synovitis when injected intraarticularly into rabbits, but the doses employed were much larger than those used in this study. We found no evidence of a transient synovitis in our guineapigs. Reddy and Lewis (1969) and Lloyd and Williams (1970) have noted an exacerbation ofjoint symptoms in patients with rheumatoid arthritis treated with iron-dextran by the total dose infusion technique, although there are no reports of similar reactions when the iron-dextran has been given in the form of a course of intravenous or intramuscular injections. Lloyd and Williams (1970) suggest that this is due to group.bmj.com on October 21, 2017 -Published by http://ard.bmj.com/ Downloaded from a delayed hypersensitivity reaction to the Dextran. It is possible that this reaction to iron-dextran represents the Auer phenomenon (Auer, 1920) , in which antigen-antibody complexes can be shown to accumulate at the site of pre-existing inflammation and to exacerbate this inflammation. Species differences may also account for the favourable response and absence of adverse reactions found in guineapigs.
From the evidence presented here it seems reasonable to postulate that the accumulation of iron in the synovial tissue of patients with rheumatoid arthritis does not cause tissue damage by the release of lysosomal enzymes (Muirden, 1966) . Indeed, it is suggested that the iron has a beneficial effect. Future studies will be needed to show whether the iron is deposited in the synovial tissue as an active process rather than as an end-result of either erythrophagocytosis following repeated small haemorrhages into the synovial fluid (Muirden, 1966 (Muirden, , 1970 or phagocytosis of iron-loaded neutrophils as suggested above.
Summary
An acute, self-limiting synovitis has been induced in one elbow joint of guinea-pigs by the intra-articular injection of Nystatin. The effects on this synovitis of intra-articular injections of iron-dextran, gold thiosulphate, and hydrocortisone acetate, and of intra-muscular injections of iron-dextran have been compared, using an external counting technique after the intravenous injection of radio-iodinated (1131) DR. MOWAT We did not use iodinated guinea-pig albumin because it was not readily available. We did some work to see where the albumin was going, and it seemed to act chiefly as a vascular marker, although about 10 per cent. of the activity was contributed by the synovial fluid and interstitial fluid.
As regards its relationship to rheumatoid arthritis, it seemed to be simply a self-limiting, acute, proliferative response. Weissmann, Pras, and Rosenberg (1967) used repeated injections of these antibiotics into joints and produced a chronic arthritis which they claimed is very like rheumatoid arthritis.
PROF. E. G. L. BYWATERS (London) Have you controlled these experiments by injecting saline (to exclude the non-specific effect of distension) and by injecting these various substances into the opposite joint? DR. MOWAT I think most of these controls have been done. We have certainly used saline and we used another obvious control, Dextran alone, which had no effect. I have not tried the effect of putting the materials into the opposite elbow joint, but this study did include the use of intramuscular injection of iron, so I think we are dealing with something specific. PROF. J. J. R. DUTHIE (Edinburgh) We have used intravenous iron for many years now and have been very satisfied with both the haematological and clinical effects. We give 200 mg. daily, 5 days a week, for 2 or 3 weeks. I saw recently a paper suggesting that iron was bad for rheumatoid joints, but the authors concerned gave a continuous infusion, which is entirely different from intermittent administration over a period of weeks. I think we should not accept this harmful effect at its face value if it is going to deprive patients of what we find to be a very useful form of treatment. I think that Dr. Mowat himself found that too large an intramuscular injection of iron produced a violent synovial reaction which subsided in a day or two. We got the impression that ultimately this joint was quieter than before. Perhaps too much iron locally (from any cause) exacerbates the condition. The other point I would like to make is that, if you give ACI7H (without administration of iron), there is a rapid rise in the serum iron. In other words, suppression of the inflammatory process alone appears to release this iron. This is against the idea that iron accumulates because of small haemorrhages. If that were so, why should suppressing the inflammation release it? I think it is active in the presence of active inflammation and that it is released from that site if the inflammation is suppressed. DR. C. F. HAWKINS (Birmingham) Are you suggesting that the anaemia of rheumatoid arthritis differs from the anaemia of other chronic infections and inflammations in which the serum iron becomes low, and do you think that the mechanism of disappearance of iron from the plasma is different? Would it not go to the reticuloendothelial system in rheumatoid patients as in those with other inflammatory diseases?
I have always been impressed with this excellent work in Edinburgh on the use of intravenous iron in rheumatoid arthritis, and I wonder whether it has been confirmed by other workers. (I do not doubt that the Edinburgh findings are true.) Finally, in the anaemia of chronic infections, does intravenous iron also reduce the inflammation, judging by other criteria such as the erythrocyte sedimentation rate?
DR. MOWAT I am sure that the anaemia of rheumatoid arthritis must be closely related to that seen in chronic infections, but there is some difference in that in rheumatoid arthritis there is what amounts to an extension of the reticuloendothelial system into the joints. We have reported large quantities of iron in this synovial tissue (Mowat and Hothersall, 1968) . I think the position is somewhat exaggerated in rheumatoid arthritis; not only is the reticuloendothelial system enlarged, but there is also a lot of proliferative tissue doing much the same thing. I am sure that the mechanism is probably very similar and the recent work on lactoferrin (Baggiolini and others, 1970 ) suggests a common pathway by which this could happen. This material, which binds iron better than transferrin in inflammatory exudates and subsequently into the reticuloendothelial system, helps to explain why there is a low plasma iron value but a normal plasma iron-binding capacity, because the transferrin has not been increased. I am not aware that other workers have substantiated the claims from Edinburgh about the anti-inflammatory effect of saccharated oxide of iron; they appear to have taken it on trust. I am not aware that anyone has tested this material in anaemia of chronic infections; they are probably more concerned with treating the particular infection.
